KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Invested Capital (2016 - 2025)

Neogenomics' Return on Invested Capital history spans 13 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 4.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, down 4.0%, while the annual FY2025 figure was 0.13%, 3.0% down from the prior year.
  • Return on Invested Capital reached 0.14% in Q4 2025 per NEO's latest filing, up from 0.14% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2021 to a low of 0.15% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.11%, with a median of 0.11% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: dropped -12bps in 2022, then increased 5bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2021, then crashed by -142bps to 0.14% in 2022, then grew by 27bps to 0.1% in 2023, then increased by 4bps to 0.1% in 2024, then tumbled by -37bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for NEO's Return on Invested Capital are 0.14% (Q4 2025), 0.14% (Q3 2025), and 0.13% (Q2 2025).